Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...

A new study reveals that sexual partners exchange unique bacterial signatures, detectable even when DNA evidence is absent.